• People
  • Locations
  • Careers

Naomi Stevens

Senior Associate

Naomi Stevens

Naomi is a Chartered UK Patent Attorney and a European Patent Attorney in the Biotechnology and Life Sciences Group.

She is experienced in the drafting, filing and prosecution of patent applications in the UK, Europe and worldwide. Naomi also has experience in the preparation of freedom-to-operate and patentability opinions and her practice spans a wide range of biotechnology areas. Naomi has particular experience in the areas of disease biomarker signatures and personalised medicine, stem cell technologies and medical devices.

Naomi previously worked at Memorial Sloan Kettering Cancer Centre in New York conducting research into cell behaviours relevant to morphogenesis and metastasis. Naomi carried out doctoral research at the Universities of Cambridge and Oxford. Her work, published in several journals including Current Biology and Developmental Cell, concerned an aspect of the cell cycle that frequently malfunctions during tumorigenesis. She has practical experience of a wide range of biochemical, molecular biology and imaging techniques.

Naomi has an MA Natural Sciences and a PhD in cancer cell biology, both from the University of Cambridge.




One Nucleus


Chartered UK Patent Attorney

European Patent Attorney

PhD Cancer Cell Biology, University of Cambridge

MPhil Developmental Biology, University of Cambridge

MA Natural Sciences (Genetics), University of Cambridge




Gene therapy

Medical devices


Scientific instruments

Practice areas

Companion diagnostics


Cancer biology

Cell biology

Imaging techniques

Molecular biology

Stem cell technologies



Nucleic acid based technologies

CPC4 Capital Park
Cambridge Rd
CB21 5XE
Download my vCard
View all insights

Contact us

    The information you submit will exclusively be used to answer your enquiry. Find out exactly how we store and use your personal data in our privacy policy.

    A European award-winning patent and trade mark firm delivering world-class advice to enhance the commercial value of intellectual property rights globally.